April 29, 2014 Regenerative medicine company Limited provided an update on its clinical programs using the product Prochymal®, which was acquired as part of the …
-
-
Choosing the Right Channel Strategy for Specialty Product Success
-
[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies
-
[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches
-
What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)
-
Accelerating Commercialization of Rare Disease Treatments
